Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
483,000
-8,500 (-1.73%)
Apr 29, 2026, 3:30 PM KST

Hanmi Pharm. Revenue

In the year 2025, Hanmi Pharm. had annual revenue of 1.55T KRW with 3.48% growth. Hanmi Pharm. had revenue of 432.96B in the quarter ending December 31, 2025, with 23.14% growth.

Revenue
1,547.53B
Revenue Growth
+3.48%
P/S Ratio
4.03
Revenue / Employee
644.80M
Employees
2,400
Market Cap
6,232.33B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251,547.53B52.03B3.48%
Dec 31, 20241,495.50B4.61B0.31%
Dec 31, 20231,490.89B159.34B11.97%
Dec 31, 20221,331.55B128.36B10.67%
Dec 31, 20211,203.19B127.33B11.84%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Yuhan 2,186.64B
Hanall Biopharma 155.18B
Celltrion Pharm 274.73B
Daewoong Pharmaceutical 1,570.89B
GC Biopharma 1,991.28B
Chong Kun Dang Pharmaceutical 1,692.40B
DongKook Pharmaceutical 926.88B
Daewoong 2,068.37B
Revenue Rankings